Snapshot Evaluation of Acute and Chronic Heart Failure in Real Life in Turkey

NCT ID: NCT02578225

Last Updated: 2018-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1054 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-31

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study, which will be conducted at 23 sites representing the determined NUTS-1 regions in Turkey, in which all patients who were admitted to clinic or were hospitalized with Heart Failure (Acute or Chronic) diagnosis will be enrolled into the study, for a month and on a day of the week which will be determined by the site itself, is a national, multi-center, observational, epidemiological and cross-sectional study. This study is a local study which is planned to be conducted only in Turkey. Included patients of the study will be clinically evaluated by the physicians who are maintaining them and will receive the standard medical treatment which is determined by their physicians in normal life conditions. No experimental intervention or treatment will be received by patients in relation to the enrollment to this study. Therefore, this study does not contain a protocol or a pre-determined visit flowchart. However, patients with Heart Failure diagnosis should grant their consent to the retrospective utilization of their data and questions which will be asked to them about their disease history. Provided that the study's design is non-pharmacological observational, investigators will treat and follow the patients in accordance with their own medical decisions and their best clinical experiences.

"Snapshot Evaluation of Heart Failure in Turkey: Initial Analysis from SELFIE-TR"

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

STUDY DESIGN STEPS

1\. The steps described below will be taken in accordance with ICD code for acute and chronic heart failure patients with a verified heart failure diagnosis:

* Verification of patient's heart failure diagnosis according to ICD code.
* In order to include the patient to the study, signing of the consent form.
* Documentation of patient demographics, medical history, heart failure history, co-morbidities and risk factors.
* Prospective recording of findings of physical examination.
* Retrospective recording of results related to diagnostic methods (biochemistry, blood count and others).
* Determination of NYHA classification.
* Determination of pathophysiology and etiology.
* Recording treatment patterns.
* Inspection of patient's device usage status (pacemaker, ICD, CRT, LVAD, transplantation).
* Inspection of hospitalization rates.

SELFIE-HF study starting date is planned as month September of 2015 and it is planned that the physicians will execute study enrollment on an allocated day of the week for 4 weeks. It is also planned that the data collected on months October and November will be inspected and listed and patients will be contacted by phone after 1 year after enrolment date in order to inquire about survival status. Therefore, estimated termination date of the study, with patient follow-up calls, is planned to be the last quarter of 2016.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non interventional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old and older male and female patients
* Disregarding the consultation method or the severity of disease, Acute Heart Failure patients who have been hospitalized
* Chronic Heart Failure patients who have been admitted to clinic
* Patients who have agreed to participate to the study

Exclusion Criteria

* Patients who have expressed their rejection for study participation
* Patients without a Heart Failure Diagnosis or whose diagnosis is changed or deemed uncertain during index application
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prof. Dr. Mehmet Birhan Yılmaz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Mehmet Birhan Yılmaz

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cukurova University School of Medicine

Adana, , Turkey (Türkiye)

Site Status

Kocatepe University School of Medicine

Afyonkarahisar, , Turkey (Türkiye)

Site Status

Hacettepe University School of Medicine

Ankara, , Turkey (Türkiye)

Site Status

Yüksek İhtisas Training and Research Hospital

Ankara, , Turkey (Türkiye)

Site Status

Adnan Menderes University School of Medicine

Aydin, , Turkey (Türkiye)

Site Status

Hitit University School of Medicine

Çorum, , Turkey (Türkiye)

Site Status

Trakya University School of Medicine

Edirne, , Turkey (Türkiye)

Site Status

Firat University School of Medicine

Elâzığ, , Turkey (Türkiye)

Site Status

Ataturk University School of Medicine

Erzurum, , Turkey (Türkiye)

Site Status

İstanbul University Cardiology Institute

Istanbul, , Turkey (Türkiye)

Site Status

Siyami Ersek Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Ege University School of Medicine

Izmir, , Turkey (Türkiye)

Site Status

İzmir Tepecik Training And Research Hospital

Izmir, , Turkey (Türkiye)

Site Status

Kilis State Hospital

Kilis, , Turkey (Türkiye)

Site Status

Kocaeli University School of Medicine

Kocaeli, , Turkey (Türkiye)

Site Status

Kirikkale University School of Medicine

Kırıkkale, , Turkey (Türkiye)

Site Status

Inonu University School of Medicine

Malatya, , Turkey (Türkiye)

Site Status

Sutcu Imam University School of Medicine

Maras, , Turkey (Türkiye)

Site Status

Mersin University School of Medicine

Mersin, , Turkey (Türkiye)

Site Status

Sakarya University School of Medicine

Sakarya, , Turkey (Türkiye)

Site Status

Ondokuz Mayis University School of Medicine

Samsun, , Turkey (Türkiye)

Site Status

Cumhuriyet University School of Medicine

Sivas, , Turkey (Türkiye)

Site Status

Karadeniz Technical University School of Medicine

Trabzon, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

288-AU/003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Uncertainty in HFrEF Patients
NCT05632198 COMPLETED
Heart Failure Evaluation Study
NCT05583513 COMPLETED